BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Törnblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002;123:1972-9. [DOI: 10.1053/gast.2002.37059] [Cited by in Crossref: 332] [Cited by in F6Publishing: 330] [Article Influence: 16.6] [Reference Citation Analysis]
Number Citing Articles
1 Shayto RH, Abou Mrad R, Sharara AI. Use of rifaximin in gastrointestinal and liver diseases. World J Gastroenterol 2016; 22(29): 6638-6651 [PMID: 27547007 DOI: 10.3748/wjg.v22.i29.6638] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
2 Shajib MS, Baranov A, Khan WI. Diverse Effects of Gut-Derived Serotonin in Intestinal Inflammation. ACS Chem Neurosci 2017;8:920-31. [DOI: 10.1021/acschemneuro.6b00414] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
3 Wen Y, Li J, Long Q, Yue C, He B, Tang X. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials. International Journal of Surgery 2020;79:111-9. [DOI: 10.1016/j.ijsu.2020.04.063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
4 Lakhan SE, Kirchgessner A. Gut inflammation in chronic fatigue syndrome. Nutr Metab (Lond) 2010;7:79. [PMID: 20939923 DOI: 10.1186/1743-7075-7-79] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
5 Collins SM. Dysregulation of peripheral cytokine production in irritable bowel syndrome. Am J Gastroenterol. 2005;100:2517-2518. [PMID: 16279908 DOI: 10.1111/j.1572-0241.2005.00246.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
6 Lee CG, Lee JK, Kang YS, Shin S, Kim JH, Lim YJ, Koh MS, Lee JH, Kang HW. Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome. Am J Gastroenterol. 2015;110:310-319. [PMID: 25583325 DOI: 10.1038/ajg.2014.422] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
7 Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010;7:146-156. [PMID: 20125092 DOI: 10.1038/nrgastro.2010.5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
8 Nightingale JMD, Paine P, McLaughlin J, Emmanuel A, Martin JE, Lal S; Small Bowel and Nutrition Committee and the Neurogastroenterology and Motility Committee of the British Society of Gastroenterology. The management of adult patients with severe chronic small intestinal dysmotility. Gut 2020;69:2074-92. [PMID: 32826308 DOI: 10.1136/gutjnl-2020-321631] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Hellström PM, Näslund E, Edholm T, Schmidt PT, Kristensen J, Theodorsson E, Holst JJ, Efendic S. GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterol Motil. 2008;20:649-659. [PMID: 18298441 DOI: 10.1111/j.1365-2982.2007.01079.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
10 Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am. 2005;34:235-245, vi-vii. [PMID: 15862932 DOI: 10.1016/j.gtc.2005.02.007] [Cited by in Crossref: 125] [Cited by in F6Publishing: 119] [Article Influence: 7.4] [Reference Citation Analysis]
11 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010;1:97-105. [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012;36:1009-31. [DOI: 10.1111/apt.12080] [Cited by in Crossref: 125] [Cited by in F6Publishing: 122] [Article Influence: 12.5] [Reference Citation Analysis]
13 Quigley EM. Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases? Chin J Dig Dis. 2005;6:122-132. [PMID: 16045602 DOI: 10.1111/j.1443-9573.2005.00202.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
14 Chen L, Yu B, Luo D, Lin M. Enteric motor dysfunctions in experimental chronic pancreatitis: Alterations of myenteric neurons regulating colonic motility in rats. Neurogastroenterol Motil 2018;30:e13301. [DOI: 10.1111/nmo.13301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hughes PA, Zola H, Penttila IA, Blackshaw LA, Andrews JM, Krumbiegel D. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol. 2013;108:1066-1074. [PMID: 23649183 DOI: 10.1038/ajg.2013.120] [Cited by in Crossref: 97] [Cited by in F6Publishing: 87] [Article Influence: 10.8] [Reference Citation Analysis]
16 Attali TV, Bouchoucha M, Benamouzig R. Treatment of refractory irritable bowel syndrome with visceral osteopathy: short-term and long-term results of a randomized trial. J Dig Dis 2013;14:654-61. [PMID: 23981319 DOI: 10.1111/1751-2980.12098] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
17 Sarna SK. Lessons Learnt from Post-Infectious IBS. Front Physiol. 2011;2:49. [PMID: 21897820 DOI: 10.3389/fphys.2011.00049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
18 Straub RH, Wiest R, Strauch UG, Härle P, Schölmerich J. The role of the sympathetic nervous system in intestinal inflammation. Gut. 2006;55:1640-1649. [PMID: 17047110 DOI: 10.1136/gut.2006.091322] [Cited by in Crossref: 143] [Cited by in F6Publishing: 130] [Article Influence: 8.9] [Reference Citation Analysis]
19 Kruis W. Commentary: symptoms of irritable bowel syndrome in patients with inflammatory bowel disease--organic disease or diseased organ? Aliment Pharmacol Ther 2013;38:440. [PMID: 23855395 DOI: 10.1111/apt.12379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Khorasanchi Z, Bahrami A, Tavallaee S, Mazloum Khorasani Z, Afkhamizadeh M, Khodashenas E, Ferns GA, Ghayour-Mobarhan M. Effect of high-dose vitamin D supplementation on antibody titers to heat shock protein 27 in adolescent girls. J Pediatr Endocrinol Metab 2020;33:613-21. [PMID: 32352398 DOI: 10.1515/jpem-2019-0288] [Reference Citation Analysis]
21 Pittock SJ, Lennon VA, Dege CL, Talley NJ, Locke GR 3rd. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci 2011;56:1452-9. [PMID: 21181442 DOI: 10.1007/s10620-010-1514-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
22 Szałwińska P, Włodarczyk J, Spinelli A, Fichna J, Włodarczyk M. IBS-Symptoms in IBD Patients-Manifestation of Concomitant or Different Entities. J Clin Med 2020;10:E31. [PMID: 33374388 DOI: 10.3390/jcm10010031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Bradesi S, Schwetz I, Ennes HS, Lamy CM, Ohning G, Fanselow M, Pothoulakis C, McRoberts JA, Mayer EA. Repeated exposure to water avoidance stress in rats: A new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol. 2005;289:G42-G53. [PMID: 15746211 DOI: 10.1152/ajpgi.00500.2004] [Cited by in Crossref: 178] [Cited by in F6Publishing: 183] [Article Influence: 10.5] [Reference Citation Analysis]
24 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012.18.3.258] [Cited by in Crossref: 98] [Cited by in F6Publishing: 91] [Article Influence: 9.8] [Reference Citation Analysis]
25 Lee EH, Yang HR, Lee HS. Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil 2016;22:459-69. [PMID: 27053514 DOI: 10.5056/jnm15174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
26 Wood JD. Neuropathophysiology of the Irritable Bowel Syndrome. Physiology of the Gastrointestinal Tract. Elsevier; 2018. pp. 1643-68. [DOI: 10.1016/b978-0-12-809954-4.00067-0] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Piche T. [Alterations of intestinal epithelial barrier and flora in the irritable bowel syndrome]. Gastroenterol Clin Biol. 2009;33 Suppl 1:S40-S47. [PMID: 19303538 DOI: 10.1016/S0399-8320(09)71524-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Hua MC, Lai MW, Kuo ML, Yao TC, Huang JL, Chen SM. Decreased interleukin-10 secretion by peripheral blood mononuclear cells in children with irritable bowel syndrome. J Pediatr Gastroenterol Nutr. 2011;52:376-381. [PMID: 21407110 DOI: 10.1097/mpg.0b013e3181fd9816] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
29 Zucchelli M, Camilleri M, Andreasson AN, Bresso F, Dlugosz A, Halfvarson J, Törkvist L, Schmidt PT, Karling P, Ohlsson B. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut. 2011;60:1671-1677. [PMID: 21636646 DOI: 10.1136/gut.2011.241877] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 8.2] [Reference Citation Analysis]
30 Crişan IM, Dumitraşcu DL. Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic Implications. Clujul Med 2014;87:73-9. [PMID: 26528001 DOI: 10.15386/cjmed-269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
31 Scherl E, Frissora CL. Irritable bowel syndrome genophenomics: correlation of serotonin-transporter polymorphisms and alosetron response. Pharmacogenomics J 2003;3:64-6. [DOI: 10.1038/sj.tpj.6500163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
32 Yuan F, Ren H, Tan W, Wang Y, Luo H. Effect of phosphodiesterase-4 inhibitor rolipram on colonic hypermotility in water avoidance stress rat model. Neurogastroenterol Motil 2022;:e14317. [PMID: 35037375 DOI: 10.1111/nmo.14317] [Reference Citation Analysis]
33 Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1075-G1084. [PMID: 22403795 DOI: 10.1152/ajpgi.00537.2011] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 6.8] [Reference Citation Analysis]
34 Ohlsson B, Gustafsson RJ, Toth E, Veress B, Thorlacius H. Endoscopic versus Laparoscopic Full-Thickness Biopsy in the Pathological Evaluation of the Enteric Nervous System. Case Rep Gastroenterol 2018;12:32-40. [PMID: 29515343 DOI: 10.1159/000486390] [Reference Citation Analysis]
35 Akiho H, Khan WI, Al-kaabi A, Blennerhassett P, Deng Y, Collins SM. Cytokine modulation of muscarinic receptors in the murine intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007;293:G250-5. [DOI: 10.1152/ajpgi.00545.2006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
36 Maifrino LB, Amaral SO, Watanabe I, Liberti EA, De Souza RR. Trypanosoma cruzi: preliminary investigation of NADH-positive and somatostatin-immunoreactive neurons in the myenteric plexus of the mouse colon during the infection. Exp Parasitol 2005;111:224-9. [PMID: 16202412 DOI: 10.1016/j.exppara.2005.08.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
37 Faure C, Righini Grunder F. Visceral Sensitivity. In: Faure C, Thapar N, Di Lorenzo C, editors. Pediatric Neurogastroenterology. Cham: Springer International Publishing; 2017. pp. 39-52. [DOI: 10.1007/978-3-319-43268-7_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Clark C, DeLegge M. Irritable bowel syndrome: a practical approach. Nutr Clin Pract 2008;23:263-7. [PMID: 18595858 DOI: 10.1177/0884533608318107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
39 Masaoka T, Vanuytsel T, Vanormelingen C, Kindt S, Salim Rasoel S, Boesmans W, De Hertogh G, Farré R, Vanden Berghe P, Tack J. A spontaneous animal model of intestinal dysmotility evoked by inflammatory nitrergic dysfunction. PLoS One 2014;9:e95879. [PMID: 24819503 DOI: 10.1371/journal.pone.0095879] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
40 De Giorgio R, Barbara G. Is irritable bowel syndrome an inflammatory disorder? Curr Gastroenterol Rep. 2008;10:385-390. [PMID: 18627650 DOI: 10.1007/s11894-008-0073-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
41 Tixier E, Galmiche JP, Neunlist M. Intestinal neuro-epithelial interactions modulate neuronal chemokines production. Biochem Biophys Res Commun 2006;344:554-61. [PMID: 16620783 DOI: 10.1016/j.bbrc.2006.03.159] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
42 Park SW, Lee H, Lee HJ, Chung H, Park JC, Shin SK, Lee SK, Lee YC. Esophageal mucosal mast cell infiltration and changes in segmental smooth muscle contraction in noncardiac chest pain. Dis Esophagus 2015;28:512-9. [PMID: 24766344 DOI: 10.1111/dote.12231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
43 Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 2015;12:36-49. [DOI: 10.1038/nrgastro.2014.200] [Cited by in Crossref: 106] [Cited by in F6Publishing: 102] [Article Influence: 13.3] [Reference Citation Analysis]
44 Villanacci V, Bassotti G, Nascimbeni R, Cathomas G, Maurer CA, Fisogni S, Salerni B. Colonic Lymphoid Aggregates in Slow Transit Constipation. Dig Dis Sci 2007;52:321-3. [DOI: 10.1007/s10620-006-9476-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
45 Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F, Keeling PW. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology. 2006;130:304-311. [PMID: 16472586 DOI: 10.1053/j.gastro.2005.11.033] [Cited by in Crossref: 407] [Cited by in F6Publishing: 405] [Article Influence: 25.4] [Reference Citation Analysis]
46 Knowles CH. New horizons in the pathogenesis of gastrointestinal neuromuscular disease. J Pediatr Gastroenterol Nutr 2007;45 Suppl 2:S97-102. [PMID: 18185077 DOI: 10.1097/MPG.0b013e31812e6569] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
47 Weinstock LB, Fern SE, Duntley SP. Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy. Dig Dis Sci. 2008;53:1252-1256. [PMID: 17934858 DOI: 10.1007/s10620-007-0021-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
48 Quigley EM. Microflora modulation of motility. J Neurogastroenterol Motil. 2011;17:140-147. [PMID: 21602990 DOI: 10.5056/jnm.2011.17.2.140] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
49 Hu J, Hu TM, He WQ, Huang YD. Effects of Huangshu Enema on the levels of serum IL-1β and IL-10 in rats with diarrhea-predominant irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2009; 17(21): 2188-2191 [DOI: 10.11569/wcjd.v17.i21.2188] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
50 ruhl A. Glial cells in the gut. Neurogastroenterol Motil 2005;17:777-90. [DOI: 10.1111/j.1365-2982.2005.00687.x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 153] [Article Influence: 9.6] [Reference Citation Analysis]
51 Ciampolini M. Requested meals versus scheduled meals. Int J Gen Med 2012;5:345-53. [PMID: 22536091 DOI: 10.2147/IJGM.S29889] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Chey WD, Cash BD. Irritable bowel syndrome: update on colonic neuromuscular dysfunction and treatment. Curr Gastroenterol Rep 2006;8:273-81. [PMID: 16888868 DOI: 10.1007/s11894-006-0047-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
53 Ju H, Liu XS, Wang GL, Yin XY, Liu H, Dai SM. Correlation between post-infective irritable bowel syndrome and cytokine expression in intestinal mucosa of patients with ulcerative colitis in remission. Shijie Huaren Xiaohua Zazhi 2007; 15(8): 844-848 [DOI: 10.11569/wcjd.v15.i8.844] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Ohlsson B, Veress B, Janciauskiene S, Montgomery A, Haglund M, Wallmark A. Chronic Intestinal Pseudo-Obstruction due to Buserelin-Induced Formation of Anti-GnRH Antibodies. Gastroenterology 2007;132:45-51. [DOI: 10.1053/j.gastro.2006.10.036] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
55 Mearin F, Perelló A, Balboa A. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?]. Gastroenterol Hepatol. 2009;32:364-372. [PMID: 19442413 DOI: 10.1016/j.gastrohep.2008.12.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
56 Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20 Suppl 2:1-9. [PMID: 15335408 DOI: 10.1111/j.1365-2036.2004.02036.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 130] [Article Influence: 6.7] [Reference Citation Analysis]
57 Soltani S, Keshteli AH, Esmaillzadeh A, Adibi P. Adherence to Dietary Approaches to Stop Hypertension Eating Plan and Prevalence of Irritable Bowel Syndrome in Adults. J Neurogastroenterol Motil 2021;27:78-86. [PMID: 33380554 DOI: 10.5056/jnm20007] [Reference Citation Analysis]
58 Vogt L, Meyer D, Pullens G, Faas M, Smelt M, Venema K, Ramasamy U, Schols HA, De Vos P. Immunological Properties of Inulin-Type Fructans. Critical Reviews in Food Science and Nutrition 2014;55:414-36. [DOI: 10.1080/10408398.2012.656772] [Cited by in Crossref: 102] [Cited by in F6Publishing: 87] [Article Influence: 12.8] [Reference Citation Analysis]
59 Wood JD. Neuropathophysiology of functional gastrointestinal disorders. World J Gastroenterol 2007; 13(9): 1313-1332 [PMID: 17457962 DOI: 10.3748/wjg.v13.i9.1313] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
60 Fan W, Fei G, Li X, Wang X, Hu C, Xin H, Sun X, Li Y, Wood JD, Fang X. Sera with anti-enteric neuronal antibodies from patients with irritable bowel syndrome promote apoptosis in myenteric neurons of guinea pigs and human SH-Sy5Y cells. Neurogastroenterol Motil 2018;30:e13457. [PMID: 30230140 DOI: 10.1111/nmo.13457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Törnblom H, Simrén M, Abrahamsson H. Gastrointestinal motility and neurogastroenterology. Scand J Gastroenterol 2015;50:685-97. [PMID: 25797147 DOI: 10.3109/00365521.2015.1027265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
62 Törnblom H, Lang B, Clover L, Knowles CH, Vincent A, Lindberg G. Autoantibodies in patients with gut motility disorders and enteric neuropathy. Scand J Gastroenterol. 2007;42:1289-1293. [PMID: 17918010 DOI: 10.1080/00365520701396216] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
63 Nwokediuko SC, Ijoma UN, Obienu O, Anigbo GE, Okafor O. High degree of duodenal inflammation in Nigerians with functional dyspepsia. Clin Exp Gastroenterol 2013;7:7-12. [PMID: 24403840 DOI: 10.2147/CEG.S54170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
64 Keller J, Layer P. Intestinal and anorectal motility and functional disorders. Best Practice & Research Clinical Gastroenterology 2009;23:407-23. [DOI: 10.1016/j.bpg.2009.02.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
65 Long Y, Wang W, Wang H, Hao L, Qian W, Hou X. Characteristics of intestinal lamina propria dendritic cells in a mouse model of postinfectious irritable bowel syndrome. J Gastroenterol Hepatol. 2012;27:935-944. [PMID: 22141367 DOI: 10.1111/j.1440-1746.2011.07046.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
66 Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol 2014; 20(27): 8886-8897 [PMID: 25083061 DOI: 10.3748/wjg.v20.i27.8886] [Cited by in F6Publishing: 30] [Reference Citation Analysis]
67 Olbe L. Concept of Crohn's disease being conditioned by four main components, and irritable bowel syndrome being an incomplete Crohn's disease. Scandinavian Journal of Gastroenterology 2009;43:234-41. [DOI: 10.1080/00365520701676971] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
68 Takenaka MC, Guereschi MG, Basso AS. Neuroimmune interactions: dendritic cell modulation by the sympathetic nervous system. Semin Immunopathol 2017;39:165-76. [PMID: 27800584 DOI: 10.1007/s00281-016-0590-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
69 Brun P, Conti J, Zatta V, Russo V, Scarpa M, Kotsafti A, Porzionato A, De Caro R, Scarpa M, Fassan M, Calistri A, Castagliuolo I. Persistent Herpes Simplex Virus Type 1 Infection of Enteric Neurons Triggers CD8+ T Cell Response and Gastrointestinal Neuromuscular Dysfunction. Front Cell Infect Microbiol 2021;11:615350. [PMID: 34094993 DOI: 10.3389/fcimb.2021.615350] [Reference Citation Analysis]
70 Vanuytsel T, Vanormelingen C, Vanheel H, Masaoka T, Salim Rasoel S, Tóth J, Houben E, Verbeke K, De Hertogh G, Vanden Berghe P, Tack J, Farré R. From intestinal permeability to dysmotility: the biobreeding rat as a model for functional gastrointestinal disorders. PLoS One 2014;9:e111132. [PMID: 25354336 DOI: 10.1371/journal.pone.0111132] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
71 Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review. Rev Gastroenterol Mex. 2014;79:96-134. [PMID: 24857420 DOI: 10.1016/j.rgmx.2014.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
72 Schaeffer DF, Kirsch R, Riddell RH. Mast cells and intestinal motility disorders (mastocytic enteritis/colitis). Dig Dis Sci 2012;57:1118-21. [PMID: 22466075 DOI: 10.1007/s10620-012-2123-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
73 Pearson JS, Whorwell PJ. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome. Curr Opin Gastroenterol 2017;33:21-5. [PMID: 28134688 DOI: 10.1097/MOG.0000000000000328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
74 Kerckhoffs A, Samsom M, van Berge Henegouwen G, Akkermans L, Nieuwenhuijs V, Visser M. Sampling Microbiota in the Human Gastrointestinal Tract. In: Ouwehand A, Vaughan E, editors. Gastrointestinal Microbiology. CRC Press; 2006. pp. 25-50. [DOI: 10.3109/9781420014952-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
75 Ohman L, Stridsberg M, Isaksson S, Jerlstad P, Simrén M. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol. 2012;107:440-447. [PMID: 22233694 DOI: 10.1038/ajg.2011.458] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
76 Hajiyeva G, Ngamruengphong S. Endoscopic techniques for full thickness intestinal biopsy. Curr Opin Gastroenterol 2018;34:295-300. [PMID: 30067562 DOI: 10.1097/MOG.0000000000000464] [Reference Citation Analysis]
77 Pensabene L, Talarico V, Concolino D, Ciliberto D, Campanozzi A, Gentile T, Rutigliano V, Salvatore S, Staiano A, Di Lorenzo C, Graziano F, Palermo BV, Sanseviero M, Altomare F, Cozza E, Falvo A, Marseglia A, Gatta E, De Venuto D, Ripepi A, Turco R. Postinfectious Functional Gastrointestinal Disorders in Children: A Multicenter Prospective Study. The Journal of Pediatrics 2015;166:903-907.e1. [DOI: 10.1016/j.jpeds.2014.12.050] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
78 González-castro AM, Martínez C, Salvo-romero E, Fortea M, Pardo-camacho C, Pérez-berezo T, Alonso-cotoner C, Santos J, Vicario M. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome: Mucosal dysfunction in irritable bowel syndrome. Journal of Gastroenterology and Hepatology 2017;32:53-63. [DOI: 10.1111/jgh.13417] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
79 Ait-Belgnaoui A, Bradesi S, Fioramonti J, Theodorou V, Bueno L. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain. 2005;113:141-147. [PMID: 15621374 DOI: 10.1016/j.pain.2004.10.002] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 6.3] [Reference Citation Analysis]
80 Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol. 2009;104:1033-1049; quiz 1050. [PMID: 19277023 DOI: 10.1038/ajg.2009.25] [Cited by in Crossref: 227] [Cited by in F6Publishing: 196] [Article Influence: 17.5] [Reference Citation Analysis]
81 Huet F, Misery L. Sensitive skin is a neuropathic disorder. Exp Dermatol 2019;28:1470-3. [DOI: 10.1111/exd.13991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
82 Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693-702. [PMID: 14988823 DOI: 10.1053/j.gastro.2003.11.055] [Cited by in Crossref: 915] [Cited by in F6Publishing: 864] [Article Influence: 50.8] [Reference Citation Analysis]
83 Beatty JK, Bhargava A, Buret AG. Post-infectious irritable bowel syndrome: Mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol 2014; 20(14): 3976-3985 [PMID: 24744587 DOI: 10.3748/wjg.v20.i14.3976] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 46] [Article Influence: 6.9] [Reference Citation Analysis]
84 Koido S, Ohkusa T, Kan S, Takakura K, Saito K, Komita H, Ito Z, Kobayashi H, Takami S, Uchiyama K, Arakawa H, Ito M, Okamoto M, Kajihara M, Homma S, Tajiri H. Production of corticotropin-releasing factor and urocortin from human monocyte-derived dendritic cells is stimulated by commensal bacteria in intestine. World J Gastroenterol 2014; 20(39): 14420-14429 [PMID: 25339828 DOI: 10.3748/wjg.v20.i39.14420] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
85 Park JH, Rhee PL, Kim G, Lee JH, Kim YH, Kim JJ, Rhee JC, Song SY. Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2006;18:539-546. [PMID: 16771769 DOI: 10.1111/j.1365-2982.2006.00771.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 3.6] [Reference Citation Analysis]
86 Drewes AM, Rössel P, Le Pera D, Arendt-Nielsen L, Valeriani M. Cortical neuroplastic changes to painful colon stimulation in patients with irritable bowel syndrome. Neurosci Lett. 2005;375:157-161. [PMID: 15694251 DOI: 10.1016/j.neulet.2004.11.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
87 Gecse K, Róka R, Séra T, Rosztóczy A, Annaházi A, Izbéki F, Nagy F, Molnár T, Szepes Z, Pávics L. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis. Digestion. 2012;85:40-46. [PMID: 22179430 DOI: 10.1159/000333083] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
88 Xiao Y, Liu Y, Huang S, Sun X, Tang Y, Cheng J, Wang T, Li F, Kuang Y, Luo R. The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials. PLoS One. 2015;10:e0122397. [PMID: 25853241 DOI: 10.1371/journal.pone.0122397] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
89 Derkinderen P, Cossais F, de Guilhem de Lataillade A, Leclair-Visonneau L, Neunlist M, Paillusson S, De Giorgio R. Gastrointestinal mucosal biopsies in Parkinson's disease: beyond alpha-synuclein detection. J Neural Transm (Vienna) 2021. [PMID: 34816335 DOI: 10.1007/s00702-021-02445-6] [Reference Citation Analysis]
90 Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, Rossi F, Lo Monte AI, Rizzo AG, Raimondo D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol 2016; 22(7): 2242-2255 [PMID: 26900287 DOI: 10.3748/wjg.v22.i7.2242] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
91 Salari P, Abdollahi M. Systematic review of modulators of benzodiazepine receptors in irritable bowel syndrome: Is there hope? World J Gastroenterol 2011; 17(38): 4251-4257 [PMID: 22090780 DOI: 10.3748/wjg.v17.i38.4251] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
92 Sarna SK. Lessons Learnt from Post-Infectious IBS. Front Physiol. 2011;2:49. [PMID: 21897820 DOI: 10.2289/fphys.2011.00049.epub] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Leung FW. Double-EMR–derived full-thickness biopsy and functional GI disorders. Gastrointestinal Endoscopy 2008;67:304-6. [DOI: 10.1016/j.gie.2007.08.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
94 Bafutto M, Almeida JR, Leite NV, Costa MB, Oliveira EC, Resende-Filho J. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii. Arq Gastroenterol. 2013;50:304-309. [PMID: 24474234 DOI: 10.1590/s0004-28032013000400012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
95 knowles CH, de giorgio R. Observations on a vestigial organ: a potential surrogate for enteric neuromesenchymal disease. Neurogastroenterol Motil 2008;20:263-8. [DOI: 10.1111/j.1365-2982.2008.01090.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
96 Rogers NJ, Mousa SA. The shortcomings of clinical trials assessing the efficacy of probiotics in irritable bowel syndrome. J Altern Complement Med. 2012;18:112-119. [PMID: 22339099 DOI: 10.1089/acm.2011.0015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
97 Verdu EF, Collins SM. Irritable bowel syndrome and probiotics: from rationale to clinical use: . Current Opinion in Gastroenterology 2005;21:697-701. [DOI: 10.1097/01.mog.0000182861.11669.4d] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
98 Limsui D, Pardi DS, Camilleri M, Loftus EV, Kammer PP, Tremaine WJ, Sandborn WJ. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007;13:175-181. [PMID: 17206699 DOI: 10.1002/ibd.20059] [Cited by in Crossref: 92] [Cited by in F6Publishing: 88] [Article Influence: 6.1] [Reference Citation Analysis]
99 Wood JD. Enteric nervous system neuropathy: repair and restoration. Curr Opin Gastroenterol 2011;27:106-11. [PMID: 21157326 DOI: 10.1097/MOG.0b013e328342a6ea] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
100 Ohlsson B, Ekblad E, Veress B, Montgomery A, Janciauskiene S. Antibodies against gonadotropin-releasing hormone (GnRH) and destruction of enteric neurons in 3 patients suffering from gastrointestinal dysfunction. BMC Gastroenterol 2010;10:48. [PMID: 20487533 DOI: 10.1186/1471-230X-10-48] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
101 Ng QX, Soh AYS, Loke W, Lim DY, Yeo WS. The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res. 2018;11:345-349. [PMID: 30288077 DOI: 10.2147/jir.s174982] [Cited by in Crossref: 70] [Cited by in F6Publishing: 43] [Article Influence: 17.5] [Reference Citation Analysis]
102 Verma-Gandhu M, Verdu EF, Bercik P, Blennerhassett PA, Al-Mutawaly N, Ghia JE, Collins SM. Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut. 2007;56:358-364. [PMID: 17018864 DOI: 10.1136/gut.2006.100016] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
103 Kuwahara Y, Kato I, Inui T, Marunaka Y, Kuwahara A. The effect of Xenin25 on spontaneous circular muscle contractions of rat distal colon in vitro. Physiol Rep 2021;9:e14752. [PMID: 33600071 DOI: 10.14814/phy2.14752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Bolino CM, Bercik P. Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role. Infect Dis Clin North Am. 2010;24:961-975, ix. [PMID: 20937460 DOI: 10.1016/j.idc.2010.07.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
105 Vazquez-Roque MI, Camilleri M, Carlson P, McKinzie S, Murray JA, Brantner TL, Burton DD, Zinsmeister AR. HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2011;23:481-487. [PMID: 21490506 DOI: 10.1097/meg.0b013e328346a56e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
106 Bassotti G, Villanacci V, Sidoni A, Nascimbeni R, Dore MP, Binda GA, Bandelloni R, Salemme M, Del Sordo R, Cadei M, Manca A, Bernardini N, Maurer CA, Cathomas G. Myenteric plexitis: A frequent feature in patients undergoing surgery for colonic diverticular disease. United European Gastroenterol J 2015;3:523-8. [PMID: 26668745 DOI: 10.1177/2050640614563822] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
107 Ramos L, Vicario M, Santos J. [Stress-mast cell axis and regulation of gut mucosal inflammation: from intestinal health to an irritable bowel]. Med Clin (Barc) 2007;129:61-9. [PMID: 17588364 DOI: 10.1157/13106939] [Reference Citation Analysis]
108 Dai YC, Tang ZP, Wang ZN, Zhang YL, Li K, He XY. Effect of Shenqing recipe on the expression of substance P and vasoactive intestine poiypeptide in TNBS-induced rat colitis. Shijie Huaren Xiaohua Zazhi 2009; 17(3): 253-258 [DOI: 10.11569/wcjd.v17.i3.253] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
109 Hod K, Ringel-Kulka T, Martin CF, Maharshak N, Ringel Y. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome. J Clin Gastroenterol. 2016;50:227-232. [PMID: 25930973 DOI: 10.1097/mcg.0000000000000327] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
110 Niu H, Xiao J. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials. International Journal of Surgery 2020;75:116-27. [DOI: 10.1016/j.ijsu.2020.01.142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
111 Brun P, Qesari M, Marconi PC, Kotsafti A, Porzionato A, Macchi V, Schwendener RA, Scarpa M, Giron MC, Palù G, Calistri A, Castagliuolo I. Herpes Simplex Virus Type 1 Infects Enteric Neurons and Triggers Gut Dysfunction via Macrophage Recruitment. Front Cell Infect Microbiol 2018;8:74. [PMID: 29600197 DOI: 10.3389/fcimb.2018.00074] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
112 Bassotti G, Chistolini F, Sietchiping Nzepa F, de Roberto G, Morelli A. Pharmacological treatment of irritable bowel syndrome: a critical assessment. Scandinavian Journal of Gastroenterology 2009;38:1013-5. [DOI: 10.1080/00365520310004029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
113 Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006;18:595-607. [PMID: 16918724 DOI: 10.1111/j.1365-2982.2005.00745.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 70] [Article Influence: 5.8] [Reference Citation Analysis]
114 Camilleri M. Treating irritable bowel syndrome: overview, perspective and future therapies. Br J Pharmacol. 2004;141:1237-1248. [PMID: 15037521 DOI: 10.1038/sj.bjp.0705741] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
115 Muller PA, Koscsó B, Rajani GM, Stevanovic K, Berres ML, Hashimoto D, Mortha A, Leboeuf M, Li XM, Mucida D, Stanley ER, Dahan S, Margolis KG, Gershon MD, Merad M, Bogunovic M. Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell 2014;158:300-13. [PMID: 25036630 DOI: 10.1016/j.cell.2014.04.050] [Cited by in Crossref: 291] [Cited by in F6Publishing: 277] [Article Influence: 36.4] [Reference Citation Analysis]
116 Hughes PA, Harrington AM, Castro J, Liebregts T, Adam B, Grasby DJ, Isaacs NJ, Maldeniya L, Martin CM, Persson J. Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes. Gut. 2012;Jul 27; Epub ahead of print. [PMID: 22767422 DOI: 10.1136/gutjnl-2011-301856] [Cited by in Crossref: 127] [Cited by in F6Publishing: 126] [Article Influence: 12.7] [Reference Citation Analysis]
117 Al-Khatib K, Lin HC. Immune activation and gut microbes in irritable bowel syndrome. Gut Liver. 2009;3:14-19. [PMID: 20479895 DOI: 10.5009/gnl.2009.3.1.14] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
118 Smith VV, Schäppi MG, Bisset WM, Kiparissi F, Jaffe A, Milla PJ, Lindley KJ. Lymphocytic Leiomyositis and Myenteric Ganglionitis Are Intrinsic Features of Cystic Fibrosis: Studies in Distal Intestinal Obstruction Syndrome and Meconium Ileus. Journal of Pediatric Gastroenterology & Nutrition 2009;49:42-51. [DOI: 10.1097/mpg.0b013e318186d35a] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
119 Storr MA, Yüce B, Andrews CN, Sharkey KA. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome. Neurogastroenterol Motil. 2008;20:857-868. [PMID: 18710476 DOI: 10.1111/j.1365-2982.2008.01175.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
120 Carroccio A, Di Prima L, Iacono G, Florena AM, D'arpa F, Sciumè C, Cefalù AB, Noto D, Averna MR. Multiple food hypersensitivity as a cause of refractory chronic constipation in adults. Scandinavian Journal of Gastroenterology 2009;41:498-504. [DOI: 10.1080/00365520500367400] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
121 Mertsalmi TH, Aho VTE, Pereira PAB, Paulin L, Pekkonen E, Auvinen P, Scheperjans F. More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota. Eur J Neurol 2017;24:1375-83. [PMID: 28891262 DOI: 10.1111/ene.13398] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 11.2] [Reference Citation Analysis]
122 Schoepfer AM, Schaffer T, Seibold-Schmid B, Müller S, Seibold F. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil. 2008;20:1110-1118. [PMID: 18694443 DOI: 10.1111/j.1365-2982.2008.01166.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 4.9] [Reference Citation Analysis]
123 Abell TL, Familoni B, Voeller G, Werkman R, Dean P, Waters B, Smalley D, Salameh JR. Electrophysiologic, morphologic, and serologic features of chronic unexplained nausea and vomiting: lessons learned from 121 consecutive patients. Surgery 2009;145:476-85. [PMID: 19375605 DOI: 10.1016/j.surg.2008.12.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
124 Kim HS, Lim JH, Park H, Lee SI. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study. Yonsei Med J. 2010;51:45-51. [PMID: 20046513 DOI: 10.3349/ymj.2010.51.1.45] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
125 Vanormelingen C, Vanuytsel T, Masaoka T, De Hertogh G, Vanheel H, Vanden Berghe P, Farré R, Tack J. The normoglycaemic biobreeding rat: a spontaneous model for impaired gastric accommodation. Gut 2016;65:73-81. [PMID: 25410165 DOI: 10.1136/gutjnl-2014-308154] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
126 Bradesi S, Tillisch K, Mayer E. Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs 2006;11:293-313. [PMID: 16634703 DOI: 10.1517/14728214.11.2.293] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
127 Layer P, Andresen V, Allescher H, Bischoff SC, Claßen M, Elsenbruch S, Freitag M, Frieling T, Gebhard M, Goebel-Stengel M, Häuser W, Holtmann G, Keller J, Kreis ME, Kruis W, Langhorst J, Jansen PL, Madisch A, Mönnikes H, Müller-Lissner S, Niesler B, Pehl C, Pohl D, Raithel M, Röhrig-Herzog G, Schemann M, Schmiedel S, Schwille-Kiuntke J, Storr M, Preiß JC, Andus T, Buderus S, Ehlert U, Engel M, Enninger A, Fischbach W, Gillessen A, Gschossmann J, Gundling F, Haag S, Helwig U, Hollerbach S, Karaus M, Katschinski M, Krammer H, Kuhlbusch-Zicklam R, Matthes H, Menge D, Miehlke S, Posovszky MC, Schaefert R, Schmidt-Choudhury A, Schwandner O, Schweinlin A, Seidl H, Stengel A, Tesarz J, van der Voort I, Voderholzer W, von Boyen G, von Schönfeld J, Wedel T; Collaborators:., in Zusammenarbeit mit:., Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)., Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)., Deutsche Gesellschaft für Ernährungsmedizin (DGEM)., Deutsche Gesellschaft für Geriatrie (DGG)., Deutsche Gesellschaft für Innere Medizin (DGIM)., Deutsche Gesellschaft für Naturheilkunde (DGNHK)., Deutsche Gesellschaft für Pathologie und Bundesverband deutscher Pathologen e. V. (DGP/BDP)., Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)., Deutsche Gesellschaft für Verhaltensmedizin und Verhaltensmodifikation (DGVM)., Deutsche Schmerzgesellschaft e. V., Deutsches Kollegium für Psychosomatische Medizin (DKPM), Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG)., Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE)., Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ)., Swiss Society of Neurogastroenterology and Motility (SwissNGM)., Informationsforum für Patient:innen mit Magen-Darm-Erkrankungen (MAGDA). Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Z Gastroenterol 2021;59:1323-415. [PMID: 34891206 DOI: 10.1055/a-1591-4794] [Reference Citation Analysis]
128 Young P, Cash BD. Probiotic use in irritable bowel syndrome. Curr Gastroenterol Rep 2006;8:321-6. [DOI: 10.1007/s11894-006-0053-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
129 Zhao K, Yu L, Wang X, He Y, Lu B. Clostridium butyricum regulates visceral hypersensitivity of irritable bowel syndrome by inhibiting colonic mucous low grade inflammation through its action on NLRP6. Acta Biochim Biophys Sin (Shanghai). 2018;50:216-223. [PMID: 29329362 DOI: 10.1093/abbs/gmx138] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
130 Bischoff SC, Schwengberg S, Lorentz A, Manns MP, Bektas H, Sann H, Levi-schaffer F, Shanahan F, Schemann M. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. Neurogastroenterol Motil 2004;16:185-93. [DOI: 10.1111/j.1365-2982.2004.00502.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
131 Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007;19:62-88. [PMID: 17280586 DOI: 10.1111/j.1365-2982.2006.00875.x] [Cited by in Crossref: 244] [Cited by in F6Publishing: 244] [Article Influence: 16.3] [Reference Citation Analysis]
132 Turcotte JF, Kao D, Mah SJ, Claggett B, Saltzman JR, Fedorak RN, Liu JJ. Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos). Gastrointest Endosc. 2013;77:624-630. [PMID: 23357497 DOI: 10.1016/j.gie.2012.11.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
133 Gardner A, Boles RG. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:730-43. [PMID: 20691744 DOI: 10.1016/j.pnpbp.2010.07.030] [Cited by in Crossref: 197] [Cited by in F6Publishing: 186] [Article Influence: 16.4] [Reference Citation Analysis]
134 Weinstock LB, Klutke CG, Lin HC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig Dis Sci. 2008;53:1246-1251. [PMID: 17932763 DOI: 10.1007/s10620-007-0022-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
135 Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18:641-661. [PMID: 15324705 DOI: org/10.1016/j.bpg.2004.04.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
136 Piche T. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil. 2014;26:296-302. [PMID: 24548256 DOI: 10.1111/nmo.12315] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 10.6] [Reference Citation Analysis]
137 Bercík P, Wang L, Verdú EF, Mao YK, Blennerhassett P, Khan WI, Kean I, Tougas G, Collins SM. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology. 2004;127:179-187. [PMID: 15236184 DOI: 10.1053/j.gastro.2004.04.006] [Cited by in Crossref: 159] [Cited by in F6Publishing: 162] [Article Influence: 8.8] [Reference Citation Analysis]
138 Meleine M, Accarie A, Wauters L, Toth J, Gourcerol G, Tack J, Farré R, Vanuytsel T. Colonic hypersensitivity and low‐grade inflammation in a spontaneous animal model for functional gastrointestinal disorders. Neurogastroenterology & Motility 2019. [DOI: 10.1111/nmo.13614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
139 Lee YJ, Park KS. Irritable bowel syndrome: Emerging paradigm in pathophysiology. World J Gastroenterol 2014; 20(10): 2456-2469 [PMID: 24627583 DOI: 10.3748/wjg.v20.i10.2456] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 65] [Article Influence: 9.9] [Reference Citation Analysis]
140 Bassotti G, Villanacci V, Mazzocchi A, Mariano M, Incardona P, Clerici C, Morelli A. Antroduodenojejunal motor activity in untreated and treated celiac disease patients. Journal of Gastroenterology and Hepatology 2008;23:e23-8. [DOI: 10.1111/j.1440-1746.2007.04868.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
141 Ishimoto H, Oshima T, Sei H, Yamasaki T, Kondo T, Tozawa K, Tomita T, Ohda Y, Fukui H, Watari J, Miwa H. Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients. J Clin Biochem Nutr 2017;60:146-50. [PMID: 28366996 DOI: 10.3164/jcbn.16-92] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
142 Barbara G, Stanghellini V, De Giorgio R, Corinaldesi R. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil. 2006;18:6-17. [PMID: 16371078 DOI: 10.1111/j.1365-2982.2005.00685.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 119] [Article Influence: 7.6] [Reference Citation Analysis]
143 Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006;101:1288-1294. [PMID: 16771951 DOI: 10.1111/j.1572-0241.2006.00672.x] [Cited by in Crossref: 311] [Cited by in F6Publishing: 308] [Article Influence: 19.4] [Reference Citation Analysis]
144 Piche T, Vanbiervliet G, Pipau FG, Dainese R, Hébuterne X, Rampal P, Collins SM. Low risk of irritable bowel syndrome after Clostridium difficile infection. Can J Gastroenterol 2007;21:727-31. [PMID: 18026576 DOI: 10.1155/2007/262478] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
145 Belkind-gerson J, Graeme-cook F, Winter H. Enteric Nervous System Disease and Recovery, Plasticity, and Regeneration. Journal of Pediatric Gastroenterology & Nutrition 2006;42:343-50. [DOI: 10.1097/01.mpg.0000218696.58487.5b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
146 Bassett JT, Cash BD. A review of irritable bowel syndrome and an update on therapeutic approaches. Expert Opinion on Pharmacotherapy 2008;9:1129-43. [DOI: 10.1517/14656566.9.7.1129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
147 Vivinus-nébot M, Frin-mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-paul MC, Tulic MK, Verhasselt V, Hébuterne X, Piche T. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 2014;63:744-52. [DOI: 10.1136/gutjnl-2012-304066] [Cited by in Crossref: 187] [Cited by in F6Publishing: 190] [Article Influence: 20.8] [Reference Citation Analysis]
148 Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. Journal of Gastroenterology and Hepatology 2008;23:1689-94. [DOI: 10.1111/j.1440-1746.2008.05574.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 115] [Article Influence: 8.0] [Reference Citation Analysis]
149 Malone MA. Irritable bowel syndrome. Prim Care 2011;38:433-47; viii. [PMID: 21872090 DOI: 10.1016/j.pop.2011.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
150 Brookes S, Chen N, Humenick A, Spencer NJ, Costa M. Extrinsic Sensory Innervation of the Gut: Structure and Function. In: Brierley S, Costa M, editors. The Enteric Nervous System. Cham: Springer International Publishing; 2016. pp. 63-9. [DOI: 10.1007/978-3-319-27592-5_7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
151 Pimentel M, Chang C. Inflammation and microflora. Gastroenterol Clin North Am. 2011;40:69-85. [PMID: 21333901 DOI: 10.1016/j.gtc.2010.12.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
152 Gwee KA. Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia. J Neurogastroenterol Motil. 2010;16:30-34. [PMID: 20535323 DOI: 10.5056/jnm.2010.16.1.30] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
153 Dai YK, Li DY, Zhang YZ, Huang MX, Zhou YL, Ye JT, Wang Q, Hu L. Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials. PLoS One 2018;13:e0192319. [PMID: 29408906 DOI: 10.1371/journal.pone.0192319] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
154 Memeo L, Jhang J, Hibshoosh H, Green PH, Rotterdam H, Bhagat G. Duodenal intraepithelial lymphocytosis with normal villous architecture: common occurrence in H. pylori gastritis. Mod Pathol 2005;18:1134-44. [DOI: 10.1038/modpathol.3800404] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 4.5] [Reference Citation Analysis]
155 Gloro R, Ducrotte P, Reimund JM. Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome? Expert Opin Ther Targets 2005;9:1079-95. [PMID: 16185159 DOI: 10.1517/14728222.9.5.1079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
156 Scanu AM, Bull TJ, Cannas S, Sanderson JD, Sechi LA, Dettori G, Zanetti S, Hermon-Taylor J. Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn’s disease and Johne’s disease: common neural and immune pathogenicities. J Clin Microbiol. 2007;45:3883-3890. [PMID: 17913930 DOI: 10.1128/jcm.01371-07] [Cited by in Crossref: 80] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
157 Bueno L, Beaufrand C, Theodorou V, Andro-Delestrain MC. Influence of simethicone and alverine on stress-induced alterations of colonic permeability and sensitivity in rats: beneficial effect of their association. J Pharm Pharmacol. 2013;65:567-573. [PMID: 23488786 DOI: 10.1111/jphp.12021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
158 López-gómez L, Bagüés A, Uranga JA, Abalo R. Preclinical models of irritable bowel syndrome. A Comprehensive Overview of Irritable Bowel Syndrome. Elsevier; 2020. pp. 233-76. [DOI: 10.1016/b978-0-12-821324-7.00012-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Turkkan E, Uslan I, Acarturk G, Topak N, Kahraman A, Dilek FH, Akcan Y, Karaman O, Colbay M, Yuksel S. Does Helicobacter pylori-induced inflammation of gastric mucosa determine the severity of symptoms in functional dyspepsia? J Gastroenterol 2009;44:66-70. [PMID: 19159074 DOI: 10.1007/s00535-008-2271-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
160 McQuade RM, Stojanovska V, Bornstein JC, Nurgali K. PARP inhibition in platinum-based chemotherapy: Chemopotentiation and neuroprotection. Pharmacol Res 2018;137:104-13. [PMID: 30278221 DOI: 10.1016/j.phrs.2018.09.031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
161 Mayer EA. Inflammation in Irritable Bowel Syndrome: Curiosity or Culprit: . Journal of Pediatric Gastroenterology and Nutrition 2004;39:S751-3. [DOI: 10.1097/00005176-200406003-00018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
162 Verdu EF. Editorial: Can gluten contribute to irritable bowel syndrome? Am J Gastroenterol. 2011;106:516-518. [PMID: 21378766 DOI: 10.1038/ajg.2010.490] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
163 Rajan E, Al-Bawardy B, Gostout CJ, Wong Kee Song LM, Deters JL, Knipschield MA, Bernard CE, Farrugia G. Endoscopic muscle biopsy sampling of the duodenum and rectum: a pilot survival study in a porcine model to detect myenteric neurons. Gastrointest Endosc 2018;87:600-6. [PMID: 28734992 DOI: 10.1016/j.gie.2017.07.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
164 Card TR, Siffledeen J, Fleming KM. Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome? Report of a case-control study in the General Practice Research Database. United European Gastroenterol J 2014;2:505-12. [PMID: 25452846 DOI: 10.1177/2050640614554217] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
165 Gulcan E, Taser F, Toker A, Korkmaz U, Alcelik A. Increased frequency of prediabetes in patients with irritable bowel syndrome. Am J Med Sci. 2009;338:116-119. [PMID: 19561452 DOI: 10.1097/MAJ.0b013e31819f7587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
166 Gonlachanvit S, Mahayosnond A, Kullavanijaya P. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity. Neurogastroenterol Motil. 2009;21:23-32. [PMID: 18647268 DOI: 10.1111/j.1365-2982.2008.01167.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 4.9] [Reference Citation Analysis]
167 Kannan R, Przekwas A. A multiscale absorption and transit model for oral drug delivery: Formulation and applications during fasting conditions. Int J Numer Method Biomed Eng 2020;36:e3317. [PMID: 32011090 DOI: 10.1002/cnm.3317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Bassotti G, Villanacci V, Antonelli E, Morelli A, Salerni B. Enteric glial cells: new players in gastrointestinal motility? Lab Invest. 2007;87:628-632. [PMID: 17483847 DOI: 10.1038/labinvest.3700564] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
169 West PW, Kelsall A, Decalmer S, Dove W, Bishop PW, Stewart JP, Woodcock AA, Smith JA. PCR based bronchoscopic detection of common respiratory pathogens in chronic cough: a case control study. Cough 2012;8:5. [PMID: 22978556 DOI: 10.1186/1745-9974-8-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
170 Rodiño-janeiro BK, Pardo-camacho C, Santos J, Martínez C. Mucosal RNA and protein expression as the next frontier in IBS: abnormal function despite morphologically intact small intestinal mucosa. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019;316:G701-19. [DOI: 10.1152/ajpgi.00186.2018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
171 Lakhan SE, Kirchgessner A. Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J Transl Med 2011;9:129. [PMID: 21810260 DOI: 10.1186/1479-5876-9-129] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 6.0] [Reference Citation Analysis]
172 Vaghari-Tabari M, Moein S, Qujeq D, Kashifard M, Alaoddolehei H, Hajian-Tilaki K. Sensitivity and specificity of mean platelet volume as a laboratory marker for irritable bowel syndrome: Can it be added to Rome criteria? Afr J Lab Med 2020;9:1001. [PMID: 33392049 DOI: 10.4102/ajlm.v9i1.1001] [Reference Citation Analysis]
173 Veress B, Nyberg B, Törnblom H, Lindberg G. Intestinal lymphocytic epithelioganglionitis: a unique combination of inflammation in bowel dysmotility: a histopathological and immunohistochemical analysis of 28 cases. Histopathology 2009;54:539-49. [PMID: 19413636 DOI: 10.1111/j.1365-2559.2009.03265.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
174 Spiller RC. Infection, immune function, and functional gut disorders. Clinical Gastroenterology and Hepatology 2004;2:445-55. [DOI: 10.1016/s1542-3565(04)00159-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
175 Fändriks L. The angiotensin II type 2 receptor and the gastrointestinal tract. J Renin Angiotensin Aldosterone Syst 2010;11:43-8. [DOI: 10.1177/1470320309347788] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
176 Knowles CH, Lindberg G, Panza E, De Giorgio R. New perspectives in the diagnosis and management of enteric neuropathies. Nat Rev Gastroenterol Hepatol. 2013;10:206-218. [PMID: 23399525 DOI: 10.1038/nrgastro.2013.18] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
177 De Giorgio R, Camilleri M. Human enteric neuropathies: Morphology and molecular pathology. Neurogastroenterol Motil. 2004;16:515-531. [PMID: 15500508 DOI: 10.1111/j.1365-2982.2004.00538.x] [Cited by in Crossref: 161] [Cited by in F6Publishing: 137] [Article Influence: 8.9] [Reference Citation Analysis]
178 Wood JD. Cellular Neurophysiology of Enteric Neurons. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 629-63. [DOI: 10.1016/b978-012088394-3/50026-x] [Cited by in Crossref: 10] [Article Influence: 0.6] [Reference Citation Analysis]
179 Knowles CH, De Giorgio R, Kapur RP, Bruder E, Farrugia G, Geboes K, Gershon MD, Hutson J, Lindberg G, Martin JE, Meier-ruge WA, Milla PJ, Smith VV, Vandervinden JM, Veress B, Wedel T. Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol 2009;118:271-301. [DOI: 10.1007/s00401-009-0527-y] [Cited by in Crossref: 145] [Cited by in F6Publishing: 121] [Article Influence: 11.2] [Reference Citation Analysis]
180 Aerssens J, Hillsley K, Peeters PJ, de Hoogt R, Stanisz A, Lin JH, Van den Wyngaert I, Göhlmann HW, Grundy D, Stead RH, Coulie B. Alterations in the brain-gut axis underlying visceral chemosensitivity in Nippostrongylus brasiliensis-infected mice. Gastroenterology 2007;132:1375-87. [PMID: 17408648 DOI: 10.1053/j.gastro.2007.02.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
181 Yamato S, Kurematsu A, Amano T, Ariga H, Ando T, Komaki G, Wada K. Urocortin 1: A putative excitatory neurotransmitter in the enteric nervous system. Neurogastroenterol Motil 2020;32:e13842. [PMID: 32196844 DOI: 10.1111/nmo.13842] [Reference Citation Analysis]
182 Ferrante M, de Hertogh G, Hlavaty T, D’Haens G, Penninckx F, D’Hoore A, Vermeire S, Rutgeerts P, Geboes K, van Assche G. The value of myenteric plexitis to predict early postoperative Crohn’s disease recurrence. Gastroenterology. 2006;130:1595-1606. [PMID: 16697723 DOI: 10.1053/j.gastro.2006.02.025] [Cited by in Crossref: 110] [Cited by in F6Publishing: 95] [Article Influence: 6.9] [Reference Citation Analysis]
183 Furness JB, Jones C, Nurgali K, Clerc N. Intrinsic primary afferent neurons and nerve circuits within the intestine. Prog Neurobiol. 2004;72:143-164. [PMID: 15063530 DOI: 10.1016/j.pneurobio.2003.12.004] [Cited by in Crossref: 236] [Cited by in F6Publishing: 216] [Article Influence: 13.1] [Reference Citation Analysis]
184 Martin-Viñas JJ, Quigley EM. Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators. J Dig Dis 2016;17:572-81. [PMID: 27426409 DOI: 10.1111/1751-2980.12379] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
185 Stark D, van Hal S, Marriott D, Ellis J, Harkness J. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol. 2007;37:11-20. [PMID: 17070814 DOI: 10.1016/j.ijpara.2006.09.009] [Cited by in Crossref: 120] [Cited by in F6Publishing: 102] [Article Influence: 7.5] [Reference Citation Analysis]
186 Bull TJ, McMinn EJ, Sidi-Boumedine K, Skull A, Durkin D, Neild P, Rhodes G, Pickup R, Hermon-Taylor J. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn’s disease. J Clin Microbiol. 2003;41:2915-2923. [PMID: 12843021 DOI: 10.1128/jcm.41.7.2915-2923.2003] [Cited by in Crossref: 270] [Cited by in F6Publishing: 123] [Article Influence: 14.2] [Reference Citation Analysis]
187 Quigley EM. Changing face of irritable bowel syndrome. World J Gastroenterol 2006; 12(1): 1-5 [PMID: 16440408 DOI: 10.3748/wjg.v12.i1.1] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
188 Lakhan SE, Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflammation. 2010;7:37. [PMID: 20615234 DOI: 10.1186/1742-2094-7-37] [Cited by in Crossref: 111] [Cited by in F6Publishing: 109] [Article Influence: 9.3] [Reference Citation Analysis]
189 Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003;125:1651-9. [DOI: 10.1053/j.gastro.2003.09.028] [Cited by in Crossref: 399] [Cited by in F6Publishing: 381] [Article Influence: 21.0] [Reference Citation Analysis]
190 Törnblom H, Abrahamsson H, Barbara G, Hellström PM, Lindberg G, Nyhlin H, Ohlsson B, Simrèn M, Sjölund K, Sjövall H, Schmidt PT, Öhman L, Group TSM. Inflammation as a cause of functional bowel disorders. Scandinavian Journal of Gastroenterology 2005;40:1140-8. [DOI: 10.1080/00365520510023657] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
191 Stierstorfer MB, Sha CT, Sasson M. Food patch testing for irritable bowel syndrome. J Am Acad Dermatol 2013;68:377-84. [PMID: 23102771 DOI: 10.1016/j.jaad.2012.09.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
192 Ma K, Liu Y, Shao W, Sun J, Li J, Fang X, Li J, Wang Z, Zhang D. Brain Functional Interaction of Acupuncture Effects in Diarrhea-Dominant Irritable Bowel Syndrome. Front Neurosci 2020;14:608688. [PMID: 33384580 DOI: 10.3389/fnins.2020.608688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
193 Piche T, Ducrotté P, Sabate JM, Coffin B, Zerbib F, Dapoigny M, Hua M, Marine-Barjoan E, Dainese R, Hébuterne X. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:626-e174. [PMID: 20403099 DOI: 10.1111/j.1365-2982.2010.01502.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
194 Quigley EM. Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics. Gastroenterol Clin North Am 2007;36:735-48, xi. [PMID: 17950446 DOI: 10.1016/j.gtc.2007.07.012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
195 Kimura T, Amano T, Uehara H, Ariga H, Ishida T, Torii A, Tajiri H, Matsueda K, Yamato S. Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon. Am J Physiol Gastrointest Liver Physiol. 2007;293:G903-G910. [PMID: 17717045 DOI: 10.1152/ajpgi.00066.2007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
196 Stewart T, Beyak MJ, Vanner S. Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons. J Physiol 2003;552:797-807. [PMID: 12923214 DOI: 10.1113/jphysiol.2003.046409] [Cited by in Crossref: 115] [Cited by in F6Publishing: 111] [Article Influence: 6.1] [Reference Citation Analysis]
197 Quigley EM. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. J Dig Dis. 2007;8:2-7. [PMID: 17261128 DOI: 10.1111/j.1443-9573.2007.00277.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
198 Kraneveld AD, Rijnierse A, Nijkamp FP, Garssen J. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets. Eur J Pharmacol. 2008;585:361-374. [PMID: 18417115 DOI: 10.1016/j.ejphar.2008.02.095] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
199 Braak B, Klooker TK, Wouters MM, Welting O, van der Loos CM, Stanisor OI, van Diest S, van den Wijngaard RM, Boeckxstaens GE. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship? Am J Gastroenterol. 2012;107:715-726. [PMID: 22488080 DOI: 10.1038/ajg.2012.54] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
200 Salvo-Romero E, Martínez C, Lobo B, Rodiño-Janeiro BK, Pigrau M, Sánchez-Chardi AD, González-Castro AM, Fortea M, Pardo-Camacho C, Nieto A, Expósito E, Guagnozzi D, Rodríguez-Urrutia A, de Torres I, Farré R, Azpiroz F, Alonso-Cotoner C, Santos J, Vicario M. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome. Sci Rep 2020;10:20706. [PMID: 33244004 DOI: 10.1038/s41598-020-77176-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
201 Drossman DA. Beyond Tricyclics: New Ideas for Treating Patients With Painful and Refractory Functional Gastrointestinal Symptoms. American Journal of Gastroenterology 2009;104:2897-902. [DOI: 10.1038/ajg.2009.341] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
202 Wu HG, Jiang B, Zhou EH, Shi Z, Shi DR, Cui YH, Kou ST, Liu HR. Regulatory mechanism of electroacupuncture in irritable bowel syndrome: preventing MC activation and decreasing SP VIP secretion. Dig Dis Sci. 2008;53:1644-1651. [PMID: 17999187 DOI: 10.1007/s10620-007-0062-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
203 Quigley EM. The Use of Probiotics in Functional Bowel Disease. Gastroenterology Clinics of North America 2005;34:533-45. [DOI: 10.1016/j.gtc.2005.05.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
204 Knowles CH, Silk DB, Darzi A, Veress B, Feakins R, Raimundo AH, Crompton T, Browning EC, Lindberg G, Martin JE. Deranged smooth muscle alpha-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series. Gut. 2004;53:1583-1589. [PMID: 15479676 DOI: 10.1136/gut.2003.037275] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 4.8] [Reference Citation Analysis]
205 Holmén N, Isaksson S, Simrén M, Sjövall H, Ohman L. CD4+CD25+ regulatory T cells in irritable bowel syndrome patients. Neurogastroenterol Motil. 2007;19:119-125. [PMID: 17244166 DOI: 10.1111/j.1365-2982.2006.00878.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
206 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol 2010; 1(3): 97-105 [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 60] [Article Influence: 4.7] [Reference Citation Analysis]
207 Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163-173. [PMID: 20101257 DOI: 10.1038/nrgastro.2010.4] [Cited by in Crossref: 362] [Cited by in F6Publishing: 353] [Article Influence: 30.2] [Reference Citation Analysis]
208 Hod K, Sperber AD, Maharshak N, Ron Y, Shapira I, David Z, Rogowski O, Berliner S, Shenhar-Tsarfaty S, Dekel R. Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls. Neurogastroenterol Motil 2018;30:e13464. [PMID: 30240124 DOI: 10.1111/nmo.13464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
209 La JH, Kim TW, Sung TS, Kang JW, Kim HJ, Yang IS. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol 2003; 9(12): 2791-2795 [PMID: 14669335 DOI: 10.3748/wjg.v9.i12.2791] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 64] [Article Influence: 3.2] [Reference Citation Analysis]
210 Fritscher-ravens A, Milla P, Ellrichmann M, Hellwig I, Böttner M, Hadeler K, Wedel T. A novel endoscopic prototype device for gastric full-thickness biopsy for the histopathologic diagnosis of GI neuromuscular pathology: in vivo porcine long-term survival study (with videos). Gastrointestinal Endoscopy 2013;77:262-71. [DOI: 10.1016/j.gie.2012.09.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
211 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012. 18.3.258] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
212 Faure C, Patey N, Gauthier C, Brooks EM, Mawe GM. Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. Gastroenterology. 2010;139:249-258. [PMID: 20303355 DOI: 10.1053/j.gastro.2010.03.032] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 8.4] [Reference Citation Analysis]
213 Kajander K, Myllyluoma E, Kyrönpalo S, Rasmussen M, Sipponen P, Mattila I, Seppänen-Laakso T, Vapaatalo H, Orešič M, Korpela R. Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome. World J Gastroenterol 2009; 15(48): 6068-6074 [PMID: 20027679 DOI: 10.3748/wjg.15.6068] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
214 Pontell L, Castelucci P, Bagyánszki M, Jovic T, Thacker M, Nurgali K, Bron R, Furness JB. Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation. Virchows Arch 2009;455:55-65. [PMID: 19517133 DOI: 10.1007/s00428-009-0795-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
215 Watthanakulpanich D, Waikagul J, Maipanich W, Nuamtanong S, Sanguankiat S, Pubampen S, Praevanit R, Mongkhonmu S, Nawa Y. Haplorchis taichui as a possible etiologic agent of irritable bowel syndrome-like symptoms. Korean J Parasitol 2010;48:225-9. [PMID: 20877501 DOI: 10.3347/kjp.2010.48.3.225] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
216 Xie MZ, Qi QH, Zhang SL, Wei MM. Effects of Dachengqi Decoction () on morphological changes in enteric nerve system of rats with multiple organ dysfunction syndrome. Chin J Integr Med 2015;21:624-9. [PMID: 25920537 DOI: 10.1007/s11655-015-1978-8] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
217 Spiller RC. Neuropathology of IBS? Gastroenterology. 2002;123:2144-2147. [PMID: 12454870 DOI: 10.1053/gast.2002.37287] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
218 O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541-551. [PMID: 15765388 DOI: 10.1053/j.gastro.2004.11.050] [Cited by in Crossref: 923] [Cited by in F6Publishing: 811] [Article Influence: 54.3] [Reference Citation Analysis]
219 Quigley EM. Do Patients with Functional Gastrointestinal Disorders have an Altered Gut Flora? Therap Adv Gastroenterol. 2009;2:23-30. [PMID: 21180551 DOI: 10.1177/1756283X09335636] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
220 Resnikoff H, Metzger JM, Lopez M, Bondarenko V, Mejia A, Simmons HA, Emborg ME. Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates. J Inflamm Res 2019;12:113-26. [PMID: 31123415 DOI: 10.2147/JIR.S196552] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
221 Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18:641-661. [PMID: 15324705 DOI: 10.1016/j.bpg.2004.04.002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
222 Malagelada C, Karunaratne TB, Accarino A, Cogliandro RF, Landolfi S, Gori A, Boschetti E, Malagelada JR, Stanghellini V, Azpiroz F, De Giorgio R. Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility. Neurogastroenterol Motil 2018;30:e13219. [DOI: 10.1111/nmo.13219] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
223 O'brien AJ, Lamb EJ, Muller AF. Renal tubular proteinuria in patients with irritable bowel syndrome: . European Journal of Gastroenterology & Hepatology 2005;17:69-72. [DOI: 10.1097/00042737-200501000-00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
224 Ohman L, Simrén M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2007;39:201-215. [PMID: 17267314 DOI: 10.1016/j.dld.2006.10.014] [Cited by in Crossref: 96] [Cited by in F6Publishing: 100] [Article Influence: 6.4] [Reference Citation Analysis]
225 knowles CH, veress B, tornblom H, wallace S, paraskeva P, darzi A, martin JE, nyberg B, lindberg G. Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospy. Neurogastroenterol Motil 2008;20:774-9. [DOI: 10.1111/j.1365-2982.2008.01099.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
226 Lacy BE, Lee RD. Irritable bowel syndrome: a syndrome in evolution. J Clin Gastroenterol. 2005;39:S230-S242. [PMID: 15798490 DOI: 10.1097/01.mcg.0000156110.69232.bb] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
227 Murch S. Allergy and Intestinal Dysmotility-Causal or Coincidental Links? Journal of Pediatric Gastroenterology & Nutrition 2005;41:S14-6. [DOI: 10.1097/01.scs.0000180289.43741.ab] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
228 Mansueto P, D’Alcamo A, Seidita A, Carroccio A. Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity. World J Gastroenterol 2015; 21(23): 7089-7109 [PMID: 26109796 DOI: 10.3748/wjg.v21.i23.7089] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
229 Kennedy PJ, Clarke G, Quigley EM, Groeger JA, Dinan TG, Cryan JF. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev. 2012;36:310-340. [PMID: 21777613 DOI: 10.1016/j.neubiorev.2011.07.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 9.4] [Reference Citation Analysis]
230 Vázquez-Frias R, Gutiérrez-Reyes G, Urbán-Reyes M, Velázquez-Guadarrama N, Fortoul-van der Goes TI, Reyes-López A, Consuelo-Sánchez A. Proinflammatory and anti-inflammatory cytokine profile in pediatric patients with irritable bowel syndrome. Rev Gastroenterol Mex 2015;80:6-12. [PMID: 25697785 DOI: 10.1016/j.rgmx.2014.11.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
231 Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther. 2005;22:387-394. [PMID: 16128676 DOI: 10.1111/j.1365-2036.2005.02579.x] [Cited by in Crossref: 239] [Cited by in F6Publishing: 206] [Article Influence: 14.1] [Reference Citation Analysis]
232 Lee YY, Annamalai C, Rao SSC. Post-Infectious Irritable Bowel Syndrome. Curr Gastroenterol Rep 2017;19. [DOI: 10.1007/s11894-017-0595-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
233 McQuade RM, Al Thaalibi M, Nurgali K. Impact of chemotherapy-induced enteric nervous system toxicity on gastrointestinal mucositis. Curr Opin Support Palliat Care 2020;14:293-300. [PMID: 32769620 DOI: 10.1097/SPC.0000000000000515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
234 Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Levy MJ, Sumiyama K, de la Mora-levy JG, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Evaluation of endoscopic approaches for deep gastric-muscle–wall biopsies: what works? Gastrointestinal Endoscopy 2008;67:297-303. [DOI: 10.1016/j.gie.2007.06.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
235 Boyer J, Saint-paul M, Dadone B, Patouraux S, Vivinus M, Ouvrier D, Michiels J, Piche T, Tulic MK. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study. Neurogastroenterol Motil 2018;30:e13223. [DOI: 10.1111/nmo.13223] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
236 Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2008;28:994-1002. [PMID: 18671775 DOI: 10.1111/j.1365-2036.2008.03818.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 109] [Article Influence: 8.6] [Reference Citation Analysis]
237 Zheng Z, Tang H. Decreased neuroplasticity may play a role in irritable bowel syndrome: implication from the comorbidity of depression and irritable bowel syndrome. J Neurogastroenterol Motil 2015;21:298-9. [PMID: 25843085 DOI: 10.5056/jnm14158] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
238 Kang YM, Lamb K, Gebhart GF, Bielefeldt K. Experimentally induced ulcers and gastric sensory-motor function in rats. Am J Physiol Gastrointest Liver Physiol. 2005;288:G284-G291. [PMID: 15388487 DOI: 10.1152/ajpgi.00250.2004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
239 Battaglia E, Bassotti G, Bellone G, Dughera L, Serra AM, Chiusa L, Repici A, Mioli P, Emanuelli G. Loss of interstitial cells of Cajal network in severe idiopathic gastroparesis. World J Gastroenterol 2006; 12(38): 6172-6177 [PMID: 17036390 DOI: 10.3748/wjg.v12.i38.6172] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
240 Valdez-Morales EE, Overington J, Guerrero-Alba R, Ochoa-Cortes F, Ibeakanma CO, Spreadbury I, Bunnett NW, Beyak M, Vanner SJ. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. Am J Gastroenterol. 2013;108:1634-1643. [PMID: 23958521 DOI: 10.1038/ajg.2013.241] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 7.7] [Reference Citation Analysis]
241 Yamamoto M, Pinto-Sanchez MI, Bercik P, Britz-McKibbin P. Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients. Metabolomics 2019;15:82. [PMID: 31111238 DOI: 10.1007/s11306-019-1543-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
242 Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol. 2011;46:421-431. [PMID: 21331765 DOI: 10.1007/s00535-011-0379-9] [Cited by in Crossref: 121] [Cited by in F6Publishing: 117] [Article Influence: 11.0] [Reference Citation Analysis]
243 Padhy SK, Sahoo S, Mahajan S, Sinha SK. Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel"? J Neurosci Rural Pract 2015;6:568-77. [PMID: 26752904 DOI: 10.4103/0976-3147.169802] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
244 Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am. 2005;34:235-245, vi-vii. [PMID: 15862932 DOI: org/10.1016/j.gtc.2005.02.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
245 Hammar O, Ohlsson B, Veress B, Alm R, Fredrikson GN, Montgomery A. Depletion of enteric gonadotropin-releasing hormone is found in a few patients suffering from severe gastrointestinal dysmotility. Scand J Gastroenterol. 2012;47:1165-1173. [PMID: 22835010 DOI: 10.3109/00365521.2012.706826] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
246 La JH, Kim TW, Sung TS, Kim HJ, Kim JY, Yang IS. Increase in neurokinin-1 receptor-mediated colonic motor response in a rat model of irritable bowel syndrome. World J Gastroenterol 2005; 11(2): 237-241 [PMID: 15633223 DOI: 10.3748/wjg.v11.i2.237] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
247 Kokkotou E, Conboy LA, Ziogas DC, Quilty MT, Kelley JM, Davis RB, Lembo AJ, Kaptchuk TJ. Serum correlates of the placebo effect in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:285-e81. [PMID: 20028464 DOI: 10.1111/j.1365-2982.2009.01440.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
248 Akiho H, Ihara E, Motomura Y, Nakamura K. Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders. World J Gastrointest Pathophysiol 2011; 2(5): 72-81 [PMID: 22013552 DOI: 10.4291/wjgp.v2.i5.72] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
249 Andrews CN, Mintchev P, Neshev E, Fraser HF, Storr M, Bathe OF, Urbanski SJ. Percutaneous endoscopically assisted transenteric full-thickness gastric biopsy: initial experience in humans. Gastrointestinal Endoscopy 2011;73:949-54. [DOI: 10.1016/j.gie.2010.12.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
250 Fung QM, Szilagyi A. Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum". Int J Inflam 2012;2012:493717. [PMID: 22518336 DOI: 10.1155/2012/493717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
251 Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1547-61; quiz 1546, 1562. [PMID: 25070051 DOI: 10.1038/ajg.2014.202] [Cited by in Crossref: 413] [Cited by in F6Publishing: 324] [Article Influence: 51.6] [Reference Citation Analysis]
252 Luo Y, Wang F, Qin J, Feng M, Lv Y, Wang Q, Liu K, Liu C. Long-term downregulation of protease-activated receptor-2 expression in distal colon in rats following bacillary dysentery. Regul Pept 2010;163:49-56. [PMID: 20347884 DOI: 10.1016/j.regpep.2010.03.002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
253 Wongtrakul W, Charoenngam N, Ungprasert P. The association between irritable bowel syndrome and osteoporosis: a systematic review and meta-analysis. Osteoporos Int 2020;31:1049-57. [PMID: 32008157 DOI: 10.1007/s00198-020-05318-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
254 Harberson J, Thomas RM, Harbison SP, Parkman HP. Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies. Dig Dis Sci. 2010;55:359-370. [PMID: 19997975 DOI: 10.1007/s10620-009-1071-2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 6.5] [Reference Citation Analysis]
255 Bernardini N, Ippolito C, Segnani C, Mattii L, Bassotti G, Villanacci V, Blandizzi C, Dolfi A. Histopathology in gastrointestinal neuromuscular diseases: methodological and ontological issues. Adv Anat Pathol. 2013;20:17-31. [PMID: 23232568 DOI: 10.1097/pap.0b013e31827b65c0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
256 Jahng J, Kim YS. Irritable Bowel Syndrome: Is It Really a Functional Disorder? A New Perspective on Alteration of Enteric Nervous System. J Neurogastroenterol Motil 2016;22:163-5. [PMID: 27032542 DOI: 10.5056/jnm16043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
257 Lam JY, Kidane B, Manji F, Taylor BM. Improved health-related quality of life after surgical management of severe refractory constipation-dominant irritable bowel syndrome. Int Surg 2015;100:63-9. [PMID: 25594641 DOI: 10.9738/INTSURG-D-13-00212.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
258 Rijnierse A, Nijkamp FP, Kraneveld AD. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol Ther. 2007;116:207-235. [PMID: 17719089 DOI: 10.1016/j.pharmthera.2007.06.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 4.8] [Reference Citation Analysis]
259 Acosta RD, Cash BD. Existing and emerging therapies for irritable bowel syndrome. Expert Opin Emerg Drugs 2011;16:389-402. [PMID: 21438740 DOI: 10.1517/14728214.2011.566214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
260 Willot S, Gauthier C, Patey N, Faure C. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2012;24:734-739, e347. [PMID: 22625872 DOI: 10.1111/j.1365-2982.2012.01933.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
261 Mearin F, Perelló A, Balboa A, Perona M, Sans M, Salas A, Angulo S, Lloreta J, Benasayag R, García-gonzalez MA, Pérez-oliveras M, Coderch J. Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: Results 3 years after gastroenteritis. Scandinavian Journal of Gastroenterology 2009;44:1173-85. [DOI: 10.1080/00365520903171276] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
262 Carroccio A, Iacono G. Review article: chronic constipation and food hypersensitivity ? an intriguing relationship. Aliment Pharmacol Ther 2006;24:1295-304. [DOI: 10.1111/j.1365-2036.2006.03125.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
263 Ohlsson B, Veress B, Lindgren S, Sundkvist G. Enteric ganglioneuritis and abnormal interstitial cells of Cajal: Features of inflammatory bowel disease. Inflammatory Bowel Diseases 2007;13:721-6. [DOI: 10.1002/ibd.20095] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
264 Eutamene H, Lamine F, Chabo C, Theodorou V, Rochat F, Bergonzelli GE, Corthésy-Theulaz I, Fioramonti J, Bueno L. Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr 2007;137:1901-7. [PMID: 17634262 DOI: 10.1093/jn/137.8.1901] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 6.3] [Reference Citation Analysis]
265 Kirsch R, Riddell RH. Histopathological alterations in irritable bowel syndrome. Mod Pathol. 2006;19:1638-1645. [PMID: 17013373 DOI: 10.1038/modpathol.3800704] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
266 Aktas G, Alcelik A, Tekce BK, Tekelioglu V, Sit M, Savli H. Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome. Prz Gastroenterol 2014;9:160-3. [PMID: 25097713 DOI: 10.5114/pg.2014.43578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
267 Li S, Fei G, Fang X, Yang X, Sun X, Qian J, Wood JD, Ke M. Changes in Enteric Neurons of Small Intestine in a Rat Model of Irritable Bowel Syndrome with Diarrhea. J Neurogastroenterol Motil 2016;22:310-20. [PMID: 26645247 DOI: 10.5056/jnm15082] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
268 Wood JD. Pathophysiology Underlying the Irritable Bowel Syndrome. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 1009-31. [DOI: 10.1016/b978-012088394-3/50044-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
269 Soares RL. Irritable bowel syndrome: A clinical review. World J Gastroenterol 2014; 20(34): 12144-12160 [PMID: 25232249 DOI: 10.3748/wjg.v20.i34.12144] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 83] [Article Influence: 11.8] [Reference Citation Analysis]
270 Toro Monjaraz EM, Vichido Luna MA, Montijo Barrios E, Cervantes Bustamante R, Zárate Mondragón F, Huante Anaya A, Cadena León J, Mendez MC, López Ugalde M, Ramirez Mayans JA. Blastocystis Hominis and Chronic Abdominal Pain in Children: Is there an Association between Them? J Trop Pediatr 2018;64:279-83. [PMID: 28985427 DOI: 10.1093/tropej/fmx060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
271 Beatty JK, Akierman SV, Motta JP, Muise S, Workentine ML, Harrison JJ, Bhargava A, Beck PL, Rioux KP, McKnight GW, Wallace JL, Buret AG. Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms. Int J Parasitol 2017;47:311-26. [PMID: 28237889 DOI: 10.1016/j.ijpara.2016.11.010] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 14.8] [Reference Citation Analysis]
272 Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the “no man’s land” of gluten sensitivity. Am J Gastroenterol. 2009;104:1587-1594. [PMID: 19455131 DOI: 10.1038/ajg.2009.188] [Cited by in Crossref: 202] [Cited by in F6Publishing: 184] [Article Influence: 15.5] [Reference Citation Analysis]
273 Keller J, Bassotti G, Clarke J, Dinning P, Fox M, Grover M, Hellström PM, Ke M, Layer P, Malagelada C, Parkman HP, Scott SM, Tack J, Simren M, Törnblom H, Camilleri M; International Working Group for Disorders of Gastrointestinal Motility and Function. Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol 2018;15:291-308. [PMID: 29622808 DOI: 10.1038/nrgastro.2018.7] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 20.0] [Reference Citation Analysis]
274 Demir IE, Schäfer KH, Tieftrunk E, Friess H, Ceyhan GO. Neural plasticity in the gastrointestinal tract: chronic inflammation, neurotrophic signals, and hypersensitivity. Acta Neuropathol. 2013;125:491-509. [PMID: 23417735 DOI: 10.1007/s00401-013-1099-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
275 Fan L, Wong M, Fan XS, Hong Y, Sun K, Jiang C, Xie X, Wang HL. Quantitative Analysis of Intramucosal Mast Cells in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease in Remission. J Clin Gastroenterol 2021;55:244-9. [PMID: 32649443 DOI: 10.1097/MCG.0000000000001394] [Reference Citation Analysis]
276 Ivison SM, Steiner TS. Anti-flagellin antibodies in irritable bowel syndrome: another attack on our commensals? Neurogastroenterol Motil 2008;20:1081-5. [PMID: 18826558 DOI: 10.1111/j.1365-2982.2008.01199.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
277 Biagi F, Luinetti O, Campanella J, Klersy C, Zambelli C, Villanacci V, Lanzini A, Corazza GR. Intraepithelial lymphocytes in the villous tip: do they indicate potential coeliac disease? J Clin Pathol. 2004;57:835-839. [PMID: 15280404 DOI: 10.1136/jcp.2003.013607] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 4.2] [Reference Citation Analysis]
278 Yang B, Zhou X, Lan C. Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome. BMC Gastroenterol. 2015;15:43. [PMID: 25886744 DOI: 10.1186/s12876-015-0272-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
279 Sommer F, Adam N, Johansson ME, Xia L, Hansson GC, Bäckhed F. Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture. PLoS One 2014;9:e85254. [PMID: 24416370 DOI: 10.1371/journal.pone.0085254] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 9.1] [Reference Citation Analysis]
280 Nam JH, Alnoah Z, Yenumula SR, Murthy S. Epidemiology, pathogenesis and treatment of irritable bowel syndrome. Expert Opinion on Therapeutic Patents 2005;13:1213-67. [DOI: 10.1517/13543776.13.8.1213] [Reference Citation Analysis]
281 Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2013;305:G529-G541. [PMID: 23886861 DOI: 10.1152/ajpgi.00207.2012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
282 Aziz I, Evans KE, Hopper AD, Smillie DM, Sanders DS. A prospective study into the aetiology of lymphocytic duodenosis. Aliment Pharmacol Ther. 2010;32:1392-1397. [PMID: 21050242 DOI: 10.1111/j.1365-2036.2010.04477.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 6.2] [Reference Citation Analysis]
283 Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Sumiyama K, Bakken TA, Stoltz GJ, Knipschield MA. Endoscopic “no hole” full-thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc. 2008;68:301-307. [PMID: 18262183 DOI: 10.1016/j.gie.2007.10.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
284 Hasler WL. Traditional thoughts on the pathophysiology of irritable bowel syndrome. Gastroenterol Clin North Am. 2011;40:21-43. [PMID: 21333899 DOI: 10.1016/j.gtc.2010.12.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
285 Halliez MC, Buret AG. Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol 2013; 19(47): 8974-8985 [PMID: 24379622 DOI: 10.3748/wjg.v19.i47.8974] [Cited by in CrossRef: 203] [Cited by in F6Publishing: 176] [Article Influence: 22.6] [Reference Citation Analysis]
286 Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9:318-331. [PMID: 25918261 DOI: 10.5009/gnl14344] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 13.0] [Reference Citation Analysis]
287 Remes-troche JM, Adames K, Castillo-rodal AI, Ramírez T, Barreto-zuñiga R, López-vidal Y, Uscanga LF. Intraepithelial γδ+ Lymphocytes: A Comparative Study Between Celiac Disease, Small Intestinal Bacterial Overgrowth, and Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2007;41:671-6. [DOI: 10.1097/01.mcg.0000247994.34957.ae] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
288 Lindberg G. Pseudo-obstruction, enteric dysmotility and irritable bowel syndrome. Best Pract Res Clin Gastroenterol. 2019;40-41:101635. [PMID: 31594655 DOI: 10.1016/j.bpg.2019.101635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
289 Bassotti G, Villanacci V, Creƫoiu D, Creƫoiu SM, Becheanu G. Cellular and molecular basis of chronic constipation: Taking the functional/idiopathic label out. World J Gastroenterol 2013; 19(26): 4099-4105 [PMID: 23864772 DOI: 10.3748/wjg.v19.i26.4099] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
290 Hojo M, Ohkusa T, Tomeoku H, Koido S, Asaoka D, Nagahara A, Watanabe S. Corticotropin-releasing factor secretion from dendritic cells stimulated by commensal bacteria. World J Gastroenterol 2011; 17(35): 4017-4022 [PMID: 22046091 DOI: 10.3748/wjg.v17.i35.4017] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
291 Holland AM, Bon-Frauches AC, Keszthelyi D, Melotte V, Boesmans W. The enteric nervous system in gastrointestinal disease etiology. Cell Mol Life Sci 2021;78:4713-33. [PMID: 33770200 DOI: 10.1007/s00018-021-03812-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
292 Hubball A, Martin JE, Lang B, De Giorgio R, Knowles CH. The role of humoral autoimmunity in gastrointestinal neuromuscular diseases. Prog Neurobiol 2009;87:10-20. [PMID: 18929621 DOI: 10.1016/j.pneurobio.2008.09.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
293 Stavely R, Robinson AM, Miller S, Boyd R, Sakkal S, Nurgali K. Human adult stem cells derived from adipose tissue and bone marrow attenuate enteric neuropathy in the guinea-pig model of acute colitis. Stem Cell Res Ther. 2015;6:244. [PMID: 26652292 DOI: 10.1186/s13287-015-0231-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
294 Andoh A, Ogawa A, Bamba S, Fujiyama Y. Interaction between interleukin-17-producing CD4+ T cells and colonic subepithelial myofibroblasts: what are they doing in mucosal inflammation. J Gastroenterol. 2007;42 Suppl 17:29-33. [PMID: 17238023 DOI: 10.1007/s00535-006-1926-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
295 İliaz R, Akyüz F, Yeğen G, Örmeci A, Göktürk S, Akyüz Ü, Baran B, Mutluay Ö, Evirgen S, Karaca Ç, Demir K, Beşışık F, Güllüoğlu M, Kaymakoğlu S. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? Turk J Gastroenterol 2018;29:384-91. [PMID: 30249551 DOI: 10.5152/tjg.2018.17491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
296 Cash BD, Chey WD. Advances in the management of irritable bowel syndrome. Curr Gastroenterol Rep 2003;5:468-75. [DOI: 10.1007/s11894-003-0035-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
297 Schemann M, Neunlist M. The human enteric nervous system. Neurogastroenterol Motil. 2004;16 Suppl 1:55-59. [PMID: 15066006 DOI: 10.1111/j.1743-3150.2004.00476.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 107] [Article Influence: 6.9] [Reference Citation Analysis]
298 Peng LH, Yang YS, Sun G, Wang WF. Proteomic analysis of colonic mucosa by two-dimensional gel electrophoresis in constipation-predominant irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2005; 13(19): 2339-2342 [DOI: 10.11569/wcjd.v13.i19.2339] [Reference Citation Analysis]
299 Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis. 2009;41:850-853. [PMID: 19740713 DOI: 10.1016/j.dld.2009.07.023] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
300 Gobert AP, Sagrestani G, Delmas E, Wilson KT, Verriere TG, Dapoigny M, Del'homme C, Bernalier-Donadille A. The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties. Sci Rep 2016;6:39399. [PMID: 27982124 DOI: 10.1038/srep39399] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
301 Lakhan SE, Kirchgessner A. Gut microbiota and sirtuins in obesity-related inflammation and bowel dysfunction. J Transl Med 2011;9:202. [PMID: 22115311 DOI: 10.1186/1479-5876-9-202] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
302 Schwetz I, Bradesi S, Mayer EA. Current insights into the pathophysiology of irritable bowel syndrome. Curr Gastroenterol Rep 2003;5:331-6. [PMID: 12864964 DOI: 10.1007/s11894-003-0071-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
303 Kellow JE, Azpiroz F, Delvaux M, Gebhart GF, Mertz HR, Quigley EM, Smout AJ. Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology. 2006;130:1412-1420. [PMID: 16678555 DOI: 10.1053/j.gastro.2005.08.061] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 4.6] [Reference Citation Analysis]
304 Traini C, Idrizaj E, Garella R, Faussone-Pellegrini MS, Baccari MC, Vannucchi MG. Otilonium Bromide treatment prevents nitrergic functional and morphological changes caused by chronic stress in the distal colon of a rat IBS model. J Cell Mol Med 2021;25:6988-7000. [PMID: 34109728 DOI: 10.1111/jcmm.16710] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
305 De Giorgio R, Guerrini S, Barbara G, Cremon C, Stanghellini V, Corinaldesi R. New insights into human enteric neuropathies. Neurogastroenterol Motil. 2004;16 Suppl 1:143-147. [PMID: 15066021 DOI: 10.1111/j.1743-3150.2004.00491.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 2.7] [Reference Citation Analysis]
306 Menees SB, Maneerattannaporn M, Kim HM, Chey WD. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107:28-35; quiz 36. [PMID: 22045120 DOI: 10.1038/ajg.2011.355] [Cited by in Crossref: 179] [Cited by in F6Publishing: 155] [Article Influence: 16.3] [Reference Citation Analysis]
307 Wood JD. Enteric Nervous System: Neuropathic Gastrointestinal Motility. Dig Dis Sci 2016;61:1803-16. [DOI: 10.1007/s10620-016-4183-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
308 Mino-kenudson M, Brown I, Lauwers G. Histopathological diagnosis of gluten-sensitive enteropathy. Current Diagnostic Pathology 2005;11:274-83. [DOI: 10.1016/j.cdip.2005.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
309 Ohman L, Lindmark AC, Isaksson S, Posserud I, Strid H, Sjövall H, Simrén M. Increased TLR2 expression on blood monocytes in irritable bowel syndrome patients. Eur J Gastroenterol Hepatol 2012;24:398-405. [PMID: 22273988 DOI: 10.1097/MEG.0b013e3283503f39] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 0.1] [Reference Citation Analysis]
310 Dlugosz A, Törnblom H, Mohammadian G, Morgan G, Veress B, Edvinsson B, Sandström G, Lindberg G. Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome. BMC Gastroenterol 2010;10:19. [PMID: 20158890 DOI: 10.1186/1471-230X-10-19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
311 Knowles CH, Martin JE. New techniques in the tissue diagnosis of gastrointestinal neuromuscular diseases. World J Gastroenterol 2009; 15(2): 192-197 [PMID: 19132769 DOI: 10.3748/wjg.15.192] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
312 Ibeakanma C, Miranda-Morales M, Richards M, Bautista-Cruz F, Martin N, Hurlbut D, Vanner S. Citrobacter rodentium colitis evokes post-infectious hyperexcitability of mouse nociceptive colonic dorsal root ganglion neurons. J Physiol. 2009;587:3505-3521. [PMID: 19470777 DOI: 10.1113/jphysiol.2009.169110] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
313 Wood JD. Pathophysiology Underlying the Irritable Bowel Syndrome. Physiology of the Gastrointestinal Tract. Elsevier; 2012. pp. 2157-81. [DOI: 10.1016/b978-0-12-382026-6.00081-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
314 Chang L, Di Lorenzo C, Farrugia G, Hamilton FA, Mawe GM, Pasricha PJ, Wiley JW. Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research. Gastroenterology. 2018;154:723-735. [PMID: 29288656 DOI: 10.1053/j.gastro.2017.12.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
315 Macsharry J, O'Mahony L, Fanning A, Bairead E, Sherlock G, Tiesman J, Fulmer A, Kiely B, Dinan TG, Shanahan F, Quigley EM. Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol. 2008;43:1467-1476. [PMID: 18752146 DOI: 10.1080/00365520802276127] [Cited by in Crossref: 103] [Cited by in F6Publishing: 112] [Article Influence: 7.9] [Reference Citation Analysis]
316 Wood JD. Cellular Neurophysiology of Enteric Neurons. Physiology of the Gastrointestinal Tract. Elsevier; 2012. pp. 629-69. [DOI: 10.1016/b978-0-12-382026-6.00021-x] [Cited by in Crossref: 9] [Article Influence: 0.9] [Reference Citation Analysis]
317 Costedio MM, Hyman N, Mawe GM. Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum. 2007;50:376-388. [PMID: 17195902 DOI: 10.1007/s10350-006-0763-3] [Cited by in Crossref: 111] [Cited by in F6Publishing: 105] [Article Influence: 7.4] [Reference Citation Analysis]
318 D’Antongiovanni V, Pellegrini C, Fornai M, Colucci R, Blandizzi C, Antonioli L, Bernardini N. Intestinal epithelial barrier and neuromuscular compartment in health and disease. World J Gastroenterol 2020; 26(14): 1564-1579 [PMID: 32327906 DOI: 10.3748/wjg.v26.i14.1564] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
319 Schemann M, Michel K, Ceregrzyn M, Zeller F, Seidl S, Bischoff SC. Human mast cell mediator cocktail excites neurons in human and guinea-pig enteric nervous system. Neurogastroenterol Motil 2005;17:281-9. [DOI: 10.1111/j.1365-2982.2004.00591.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
320 Hod K, Sperber AD, Ron Y, Boaz M, Dickman R, Berliner S, Halpern Z, Maharshak N, Dekel R. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS. Neurogastroenterol Motil. 2017;29. [PMID: 28271623 DOI: 10.1111/nmo.13037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
321 Bassotti G, Villanacci V, Fisogni S, Rossi E, Baronio P, Clerici C, Maurer CA, Cathomas G, Antonelli E. Enteric glial cells and their role in gastrointestinal motor abnormalities: Introducing the neuro-gliopathies. World J Gastroenterol 2007; 13(30): 4035-4041 [PMID: 17696219 DOI: 10.3748/wjg.v13.i30.4035] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
322 lebouvier T, coron E, chaumette T, paillusson S, des varannes SB, neunlist M, derkinderen P. Routine colonic biopsies as a new tool to study the enteric nervous system in living patients. Neurogastroenterology & Motility 2009. [DOI: 10.1111/j.1365-2982.2009.01368.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
323 Wood JD, Liu S, Drossman DA, Ringel Y, Whitehead WE. Anti-enteric neuronal antibodies and the irritable bowel syndrome. J Neurogastroenterol Motil. 2012;18:78-85. [PMID: 22323991 DOI: 10.5056/jnm.2012.18.1.78] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
324 Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101:1581-1590. [PMID: 16863564 DOI: 10.1111/j.1572-0241.2006.00734.x] [Cited by in Crossref: 521] [Cited by in F6Publishing: 437] [Article Influence: 32.6] [Reference Citation Analysis]
325 Hisamatsu T, Inoue N, Yajima T, Izumiya M, Ichikawa H, Hibi T. Psychological aspects of inflammatory bowel disease. J Gastroenterol. 2007;42 Suppl 17:34-40. [PMID: 17238024 DOI: 10.1007/s00535-006-1937-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
326 Ohashi-Doi K, Himaki D, Nagao K, Kawai M, Gale JD, Furness JB, Kurebayashi Y. A selective, high affinity 5-HT 2B receptor antagonist inhibits visceral hypersensitivity in rats. Neurogastroenterol Motil. 2010;22:e69-e76. [PMID: 19740115 DOI: 10.1111/j.1365-2982.2009.01395.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
327 Sullivan A, Törnblom H, Lindberg G, Hammarlund B, Palmgren AC, Einarsson C, Nord CE. The micro-flora of the small bowel in health and disease. Anaerobe 2003;9:11-4. [PMID: 16887682 DOI: 10.1016/S1075-9964(03)00060-X] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
328 Li C, Shuai Y, Zhou X, Chen H. Association between Helicobacter pylori infection and irritable bowel syndrome: A systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22975. [PMID: 33327230 DOI: 10.1097/MD.0000000000022975] [Reference Citation Analysis]
329 Serra J, Villoria A, Azpiroz F, Lobo B, Santos J, Accarino A, Malagelada JR. Impaired intestinal gas propulsion in manometrically proven dysmotility and in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:401-406, e91-e92. [PMID: 20047636 DOI: 10.1111/j.1365-2982.2009.01447.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
330 Spak E, Casselbrant A, Olbers T, Lönroth H, Fändriks L. Angiotensin II-induced contractions in human jejunal wall musculature in vitro. Acta Physiol (Oxf) 2008;193:181-90. [PMID: 18081740 DOI: 10.1111/j.1748-1716.2007.01826.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
331 Quigley EM. Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon. Gastroenterol Clin North Am. 2005;34:221-233, vi. [PMID: 15862931 DOI: 10.1016/j.gtc.2005.02.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
332 Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut. 2016;65:155-168. [PMID: 26194403 DOI: 10.1136/gutjnl-2015-309151] [Cited by in Crossref: 147] [Cited by in F6Publishing: 144] [Article Influence: 21.0] [Reference Citation Analysis]
333 Bradesi S, McRoberts JA, Anton PA, Mayer EA. Inflammatory bowel disease and irritable bowel syndrome: Separate or unified? Curr Opin Gastroenterol. 2003;19:336-342. [PMID: 15703574 DOI: 10.1097/00001574-200307000-00003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
334 Kodani M, Fukui H, Tomita T, Oshima T, Watari J, Miwa H. Association between gastrointestinal motility and macrophage/mast cell distribution in mice during the healing stage after DSS‑induced colitis. Mol Med Rep 2018;17:8167-72. [PMID: 29693127 DOI: 10.3892/mmr.2018.8926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
335 Gargala G, Lecleire S, François A, Jacquot S, Déchelotte P, Ballet JJ, Favennec L, Ducrotté P. Duodenal intraepithelial T lymphocytes in patients with functional dyspepsia. World J Gastroenterol 2007; 13(16): 2333-2338 [PMID: 17511033 DOI: 10.3748/wjg.v13.i16.2333] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
336 Peláez-luna M, Schmulson M, Robles-díaz G. Intestinal involvement is not sufficient to explain hypertransaminasemia in celiac disease? Medical Hypotheses 2005;65:937-41. [DOI: 10.1016/j.mehy.2005.05.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
337 Carroccio A, Scalici C, Maresi E, Prima LD, Cavataio F, Noto D, Porcasi R, Averna MR, Iacono G. Chronic constipation and food intolerance: A model of proctitis causing constipation. Scandinavian Journal of Gastroenterology 2009;40:33-42. [DOI: 10.1080/00365520410009401] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
338 larsson*,‡ MH, simrén M, thomas EA, bornstein JC, lindström E, sjövall H. Elevated motility-related transmucosal potential difference in the upper small intestine in the irritable bowel syndrome. Neurogastroenterol Motil 2007;19:812-20. [DOI: 10.1111/j.1365-2982.2007.00941.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]